Why the study?
Does viral culture of cerebrospinal fluid provide additional diagnostic benefit over nucleic acid amplification testing?
Does viral culture of cerebrospinal fluid provide additional diagnostic benefit over nucleic acid amplification testing?
Viral culture of cerebrospinal fluid offers minimal additional diagnostic benefit when nucleic acid amplification testing is performed.
Answers are grounded in this paper and cite their sources.
CSF viral culture adds minimal value beyond NAAT; leaves open whether routine use should be abandoned.
Nucleic acid amplification testing is the preferred method to detect enteroviruses and Herpesviridae in cerebrospinal fluid, but clinicians still request viral culture. Review of 22,394 viral cultures of cerebrospinal fluid samples found that <0.1% recovered nonenterovirus, non-Herpesviridae species, suggesting that, when nucleic acid amplification testing is performed, viral culture may have no additional benefit.
No takes yet. Share an insight, caveat, or question.
Polage et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: